Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Ostfold Hospital Trust, Moss, Moss, Ostfold, Norway
Oslo Universitetssykehus, Ullevaal, dept of anaesthesiology, legevakten, Oslo, Norway
Hospital Infantil Albert Sabin, Fortaleza, Ceara, Brazil
Kuala Lumpur General Hospital, Kuala Lumpur, Wilayah Persekutuan, Malaysia
VA Western New York Healthcare System, Buffalo, New York, United States
Medical University of Silesia, Sosnowiec, Silesia, Poland
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.